Literature DB >> 35947237

A clinical and electrophysiological case study of a child with a novel frame shift mutation in the CACNA1F and missense variation of RIMS1 genes.

P Weston1, D Taranath2, J Liebelt3, N Smith4.   

Abstract

PURPOSE: The purpose of this paper is to present a case study illustrating the importance of electrophysiological investigation in the diagnosis and serial monitoring of isolated congenital nystagmus.
RESULTS: Serial electophysiological monitoring was undertaken in the male proband over a 9-year period commencing with initial assessment at 12 weeks of age: Skin electroretinograms (sERGs) were initially absent but subsequently revealed low-amplitude responses, electronegative morphologies and notched flicker responses suggestive of incomplete congenital stationary night blindness (CSNB2), but with an absent dark-adapted rod-specific response, while flash visual evoked potentials (fVEPs) demonstrated persistent crossed asymmetry, typical of albinoid misrouting of the optic nerves. Molecular investigation confirmed a novel hemizygous frame shift mutation in the CACNA1F gene, considered to be pathogenic and causative of X-linked CSNB2; additionally, a novel heterozygous missense variation in one copy of the RIMS1 gene was identified, pathogenic mutations of which underpin late-onset autosomal dominant cone-rod dystrophy (type 7). Segregation studies confirmed maternal inheritance of both mutations in the clinically asymptomatic mother in whom depressed rod-specific responses were confirmed on sERG. The child's visual acuity has remained stable as have the sERGs which have been verified by recordings using scleral electrodes.
CONCLUSIONS: The importance of recording ERGs as part of evaluating infants who present with nystagmus, even with a normal fundus appearance, is supported. Further, sERGs were able to distinguish an apparent variant of CSNB2 and could give consistent results over many years. FVEP results add to the evidence that albinoid misrouting of the optic nerves may occur in cases of CSNB2. ERGs and fVEPs can provide valuable information in discriminating the relative diagnostic importance of multiple genetic abnormalities.
© 2022. Crown.

Entities:  

Keywords:  CACNA1F; CSNB2; Crossed asymmetry; Electroretinogram; Flash visual evoked potential; Incomplete congenital stationary night blindness; Nystagmus; RIMS1 electronegative; Retina

Mesh:

Substances:

Year:  2022        PMID: 35947237     DOI: 10.1007/s10633-022-09892-w

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   1.854


  6 in total

1.  Visual evoked potentials with crossed asymmetry in incomplete congenital stationary night blindness.

Authors:  F Tremblay; I De Becker; C Cheung; G R LaRoche
Journal:  Invest Ophthalmol Vis Sci       Date:  1996-08       Impact factor: 4.799

2.  Characteristic ERG-flicker anomaly in incomplete congenital stationary night blindness.

Authors:  Y Miyake; M Horiguchi; I Ota; N Shiroyama
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-11       Impact factor: 4.799

3.  Novel CACNA1F mutations in Japanese patients with incomplete congenital stationary night blindness.

Authors:  M Nakamura; S Ito; H Terasaki; Y Miyake
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-06       Impact factor: 4.799

4.  Variable expressivity in X-linked congenital stationary night blindness.

Authors:  W G Pearce; M Reedyk; S G Coupland
Journal:  Can J Ophthalmol       Date:  1990-02       Impact factor: 1.882

5.  Identification of a novel heterozygous missense mutation in the CACNA1F gene in a chinese family with retinitis pigmentosa by next generation sequencing.

Authors:  Qi Zhou; Jingliang Cheng; Weichan Yang; Mousumi Tania; Hui Wang; Md Asaduzzaman Khan; Chengxia Duan; Li Zhu; Rui Chen; Hongbin Lv; Junjiang Fu
Journal:  Biomed Res Int       Date:  2015-05-17       Impact factor: 3.411

6.  ISCEV Standard for full-field clinical electroretinography (2022 update).

Authors:  Anthony G Robson; Laura J Frishman; John Grigg; Ruth Hamilton; Brett G Jeffrey; Mineo Kondo; Shiying Li; Daphne L McCulloch
Journal:  Doc Ophthalmol       Date:  2022-05-05       Impact factor: 1.854

  6 in total
  1 in total

1.  Response to: No strong evidence to date for an association between RIMS1 and retinal dystrophy: Mahrood O, et al.

Authors:  P Weston; D Taranath; J Liebelt; N Smith
Journal:  Doc Ophthalmol       Date:  2022-10-17       Impact factor: 1.854

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.